Skip to main content
Log in

Human Genome and Diseases: Review¶Transcription factor GATA3 and the human HDR syndrome

  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Recently, a member of the GATA-binding family of transcription factors was shown to be involved in the human hypoparathyroidism, sensorineural deafness and renal anomalies (HDR) syndrome. Deletion-mapping studies and subsequent mutation analysis revealed that haploinsufficiency for GATA3 is the underlying mechanism of the HDR syndrome. Here we discuss the clinical characteristics of the HDR syndrome and present an overview of the role of GATA3 and related GATA-binding transcription factors during vertebrate embryonic development and their involvement in human disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received 12 February 2001; received after revision 28 March 2001; accepted 28 March 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Esch, H., Devriendt, K. Human Genome and Diseases: Review¶Transcription factor GATA3 and the human HDR syndrome. CMLS, Cell. Mol. Life Sci. 58, 1296–1300 (2001). https://doi.org/10.1007/PL00000940

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00000940

Navigation